Non-apoptotic forms of cell death can trigger sterile inflammation through the release of danger-associated molecular patterns, which are recognized by innate immune receptors. However, despite years of investigation the mechanisms which initiate inflammatory responses after heart transplantation remain elusive. Here, we demonstrate that ferrostatin-1 (Fer-1), a specific inhibitor of ferroptosis, decreases the level of proferroptotic hydroperoxy-arachidonoyl-phosphatidylethanolamine, reduces cardiomyocyte cell death and blocks neutrophil recruitment following heart transplantation. Inhibition of necroptosis had no effect on neutrophil trafficking in cardiac grafts. We extend these observations to a model of coronary artery ligation-induced myocardial ischemia reperfusion injury where inhibition of ferroptosis resulted in reduced infarct size, improved left ventricular systolic function, and reduced left ventricular remodeling. Using intravital imaging of cardiac transplants, we uncover that ferroptosis orchestrates neutrophil recruitment to injured myocardium by promoting adhesion of neutrophils to coronary vascular endothelial cells through a TLR4/Trif/type I IFN signaling pathway. Thus, we have discovered that inflammatory responses after cardiac transplantation are initiated through ferroptotic cell death and TLR4/Trif-dependent signaling in graft endothelial cells.
Non-apoptotic forms of cell death can trigger sterile inflammation through the release of danger-associated molecular patterns, which are recognized by innate immune receptors. However, despite years of investigation the mechanisms which initiate inflammatory responses after heart transplantation remain elusive. Here, we demonstrate that ferrostatin-1 (Fer-1), a specific inhibitor of ferroptosis, decreases the level of pro-ferroptotic hydroperoxyarachidonoyl-phosphatidylethanolamine, reduces cardiomyocyte cell death and blocks neutrophil recruitment following heart transplantation. Inhibition of necroptosis had no effect on neutrophil trafficking in cardiac grafts. We extend these observations to a model of coronary artery ligation-induced myocardial ischemia reperfusion injury where inhibition of ferroptosis resulted in reduced infarct size, improved left ventricular systolic function, and reduced left ventricular remodeling. Using intravital imaging of cardiac transplants, we uncover that ferroptosis orchestrates neutrophil recruitment to injured myocardium by promoting adhesion of neutrophils to coronary vascular endothelial cells through a TLR4/TRIF/type I IFN signaling pathway. Thus, we have discovered that inflammatory responses after cardiac transplantation are initiated through ferroptotic cell death and TLR4/Trif-dependent signaling in graft endothelial cells. These findings provide a platform for the development of therapeutic strategies for heart transplant recipients and patients, who are vulnerable to ischemia reperfusion injury following restoration of coronary blood flow.
Introduction
Ischemia reperfusion injury (IRI) following heart transplantation is a clinically significant form of sterile inflammation. IRI-mediated primary graft dysfunction complicates the postoperative course of up to 28% of human cardiac transplant recipients (1) . Of note, the development of primary graft dysfunction can result in an early mortality rate of approximately 10% and is also associated with significantly lower survival rates at one year after transplantation (2) . While several donor and recipient factors have been identified as risk factors for the development of primary graft dysfunction after heart transplantation, the cellular and molecular mechanisms by which IRI induces myocardial inflammation are not well understood.
Neutrophils are recruited to sites of sterile inflammation. For example, our group and others have reported that neutrophils are critical mediators of primary graft dysfunction after lung transplantation (3) . Similarly, neutrophils are also recruited to injured myocardium in humans and experimental animals, where they cause tissue damage (4) . It is the prevailing notion that neutrophil recruitment during sterile injury is triggered through the release of damage-associated molecular patterns (DAMPs) from dead cells and subsequent engagement of innate immune receptors such as toll like receptors (TLRs) (5) . TLR activation initiates signaling via the adaptor proteins MyD88 or Trif. Our current understanding is that following ischemia reperfusion injury, cells die through a combination of apoptosis and non-apoptotic forms of programmed cell death (6) . It is further postulated that non-apoptotic forms of programmed cell death such as necroptosis or ferroptosis result in the release of DAMPs that ultimately result in the initiation of inflammation, referred to as necroinflammation (7) . The precise cell death pathways and signaling events that orchestrate early inflammation after heart transplantation are unknown.
The cellular and molecular requirements that regulate specific steps of neutrophil trafficking differ between various tissues and organs (8) . Our laboratory has developed methods to image beating murine hearts by intravital two-photon microscopy, which allows for a detailed analysis of leukocyte trafficking in cardiac grafts in real time (9) .
Using this approach, we have recently described that neutrophil extravasation into reperfused transplanted hearts is mediated by tissue-resident CCR2 + macrophages through a TLR9/MyD88-dependent pathway (10) . Here, we took advantage of intravital imaging to examine the pathways that regulate the initial recruitment of neutrophils to cardiac grafts. We have discovered that the early cues allowing neutrophils to slow down in the vasculature and to adhere to the vessel wall during IRI are mediated through ferroptotic cell death and TLR4/Trif-dependent signaling in graft endothelial cells.
Results

Ferroptosis regulates cell death and neutrophil recruitment after heart transplantation
To interrogate the initial recruitment of neutrophils by intravital two-photon imaging following cardiac transplantation we engrafted B6 wildtype hearts into syngeneic B6 LysM-GFP neutrophil reporter mice (9, 10) . Consistent with our previous reports, neutrophils are rapidly recruited to heart grafts immediately following reperfusion ( Figure   1A , Supplemental Video 1). Only few cardiomyocytes stained for cleaved caspase-3 in these grafts and we did not observe differences in neutrophil recruitment kinetics after treating recipient mice with the pan-caspase inhibitor Z-VAD-FMK (Supplemental Figure   1 , Supplemental Video 2). These findings indicate that classical apoptotic pathways of cell death in the cardiac graft do not play an important role in the regulation of early neutrophil recruitment following reperfusion. Treatment of heart recipients with the RIPK1 inhibitor necrostatin-1 (Nec-1) at the time of transplantation, however, resulted in significant increases in rolling velocities. Very few neutrophils slowed down sufficiently to transition to adherence to the walls of the coronary veins ( Fig. 1 B, E; Supplemental Video 3). Consequently, we observed significant reductions in their density and also an impairment in their extravasation ( Fig. 1 F, G) . Nec-1 has been frequently used to block necroptosis in various experimental systems (11) . To test the role of necroptosis genetically, we next transplanted hearts that lack expression of RIPK3, a kinase that is essential in triggering necroptosis (12) . Transplantation of RIPK3-deficient hearts mirrored neutrophil behavior observed after engraftment of wildtype hearts (Fig. 1C , E-G; Supplemental Video 4). As reports exist that Nec-1 can inhibit both necroptosis and ferroptosis we next interrogated the ferroptotic pathway of cell death (13) . Treatment of heart recipients with ferrostatin (Fer-1), a selective inhibitor of ferroptosis (14) , yielded results similar to those observed after administration of Nec-1 ( Fig Fig. 3 ). In addition, through oxidative lipidomics we determined that a specific lipid peroxidation product, hydroperoxy-arachidonoylphosphatidylethanolamine (HOO-C20:4/C18:0-PE) that acts as a ferroptotic death signal, was reduced in whole tissue homogenates obtained from cardiac grafts after treatment with Fer-1(15) ( Fig. 1K ).
Ferroptosis mediates cell death and tissue injury after non-transplant-related myocardial IRI
To examine whether ferroptosis is responsible for cardiomyocyte cell death following IRI in the absence of exogenous immune cell recruitment, we employed Langendorff preparations. We observed that hearts subjected to 1 hour of ischemia displayed a marked increase in total creatinine kinase (CK) activity released over a 30minute reperfusion period compared to control hearts that were not subjected to ischemia.
Hearts treated with Fer-1 demonstrated reduced levels of released total CK activity compared to vehicle-treated controls following IRI ( Fig. 2A ). Serial measurements of released CK activity revealed that Fer-1 decreased CK release after 15 minutes of reperfusion suggesting that ferroptosis may be selectively impacting cardiomyocyte cell death that occurs as a result of IRI rather than ischemia alone ( 
Early steps of neutrophil recruitment after heart transplantation are mediated through a TLR4/Trif-dependent pathway
Ferroptosis is an inflammatory form of regulated cell death that results in loss of plasma membrane integrity and the release of DAMPs. Many DAMPs that are released from dying cells in injured tissues elicit responses by signaling through TLR4 (19) .
Furthermore, TLR4 has been shown to play a role in promoting myocardial IRI (20) .
Therefore, we next set out to evaluate the role of TLR4 expression in cardiac grafts on neutrophil trafficking in reperfused cardiac grafts. Similar to our observations after treatment of heart recipients with Fer-1, in TLR4-deficient compared to wildtype hearts very few neutrophils adhered to the vessel walls, their density and extravasation was significantly reduced and their rolling velocity was significantly increased (Fig. 3A 
Type I interferon signaling regulates early steps of neutrophil recruitment to transplanted hearts
Trif-mediated signaling stimulates the production of Type I interferons, a process that is regulated by the transcription factors IRF3, IRF5 and IRF7 (22) . Donor hearts that lacked expression of type I interferon receptor (IFNAR) or the combination of IRF3, IRF5
and IRF7 displayed increased neutrophil rolling velocity, failure of neutrophils to adhere to the vessel wall, and marked reductions in neutrophil extravasation into the myocardium compared to wildtype grafts ( Fig. 4 
Neutrophilic infiltration of injured hearts mediates tissue damage
Having shown that ferroptotic cell death regulates the recruitment of neutrophils into injured myocardium we next set out to examine whether neutrophilic accumulation contributes to cardiac damage. We subjected B6 mice that lacked expression of TLR4 on endothelial cells (Tie2-Cre/TLR4 fl/fl ), TLR4 fl/fl control mice and neutrophil-depleted B6 mice to myocardial IRI in an in vivo closed-chest model. We observed significant reductions in neutrophilic infiltration into injured Tie2-Cre/TLR4 fl/fl , comparable to the levels seen in neutrophil-depleted animals ( Fig. 5A, B ). We found that either deletion of 
Discussion
Mechanisms guiding leukocyte recruitment differ between various tissues and organs. Intravital two-photon imaging has enabled us to gain novel insights into cellular and molecular cues that regulate neutrophil recruitment into injured hearts (9) . Our Interestingly, type I interferon signaling has been shown to contribute to the production of CXCL2 in models of kidney IRI (23 (20) . While these studies did not address the question which cells were activated through TLR4, a few reports have suggested a role for macrophages. Zhu proposed a cascade whereby DAMPs mediate the production of IL-23 by macrophages through TLR4-dependent signaling in transplanted hearts (27) . IL-23 promoted the generation of IL-17 +  T cells, which resulted in the recruitment of neutrophils to the graft. TLR4 signaling in hematopoietic cells has also been suggested to mediate hepatic IRI (28) . In a model of warm liver IRI, Zhai demonstrated that inflammation was mediated through TLR4 signaling in macrophages, which resulted in MyD88-independent IRF3-dependent production of type I interferons (29, 30) .
The Kubes laboratory has published several reports examining how TLR4 and CD14 expression regulate neutrophil recruitment into the capillary beds of various organs and tissues after local or systemic endotoxin challenges. Andonegui showed that TLR4 expression by endothelial cells regulates neutrophil sequestration into lung and brain capillaries following systemic administration of LPS (31) (32) . Tissue-specific variations exist with regard to dependence on CD14 expression for leukocyte sequestration in response to LPS (33) . To this end, unlike our observations in reperfused cardiac grafts, endotoxin-mediated neutrophil sequestration into the microcirculation of the central nervous system or liver was not dependent on CD14 expression (32, 34) .
It has become widely accepted that non-apoptotic forms of cardiomyocyte cell death result in the release of alarmins and DAMPs that ultimately result in the initiation of inflammation, referred to as necroinflammation (7, 35) . Various cell death signaling pathways have been considered to be involved in myocardial injury. A recent study demonstrated that inhibition of glutaminolysis, a pathway that can induce ferroptotic cell death, resulted in functional improvements in hearts subjected to IRI in an ex vivo preparation (36) . Consistent with these observations, we have shown that treatment with
Fer-1 reduced the abundance of several oxidized lipids that have been associated with ferroptosis and decreased the release of CK. However, the initial driver of cardiomyocyte death following IRI in vivo has not been conclusively identified. We have demonstrated that ferroptosis mediates early cell death and promotes the initial stages of inflammation following heart transplantation and also during myocardial IRI after transient occlusion of a coronary artery. Intriguingly, we found that cells within the myocardium are differentially responsive to ferroptosis. Cardiomyocytes and fibroblasts, but not endothelial cells, appeared to be most vulnerable to ferroptotic cell death. Ferroptosis has recently been described as a form of programmed cell death that has been implicated in various pathologies including malignancies, neurodegeneration, and IRI involving the kidney and brain (37) (38) (39) (40) (41) . Biochemically, ferroptosis is dependent on the generation of lipid peroxides, particularly hydroperoxides of polyunsaturated (arachidonoyl) phosphatidylethanolamines (42) . Manipulations that interfere with the production of lipid peroxides result in resistance to ferroptosis, and, conversely, inhibition of cellular mechanisms that eliminate lipid peroxides sensitizes cells to ferroptosis (15, 43, 44) .
Many of the biochemical mechanisms essential for ferroptosis have been observed in the context of myocardial IRI (45) . In addition, enzymatic activities required to execute ferroptosis are also important for cardiomyocyte cell death (46) . Notably, a recent study has shown that inhibition of ferroptosis reduces cardiac dysfunction in a model of pressure overload-induced heart failure suggesting a role for ferroptotic cell death beyond the stages immediately following the injury (47) .
Similar to our observations, treatment with Nec-1 has been shown to have a protective effect in models of heart IRI (48) . However, as Nec-1 can inhibit both necroptosis and ferroptosis, no definitive conclusions about the cell death pathways could be drawn from these investigations. Previous studies using RIPK3-deficient mice have suggested that necroptotic cell death may play a role at later time points after heart injury (12) . For example, RIPK3-deficient heart allografts demonstrated less cell death, attenuation in lymphocytic infiltrates and reduced levels of DAMPs 12 days after transplantation into allogeneic hosts (49) . We suggest that necroptotic death of graft cells is triggered by tissue-resident or infiltrating immune cells releasing inflammatory mediators, such as TNF-α (49). This notion is supported by our demonstration that neutrophilic infiltration into injured hearts, a process that is triggered by ferroptosis, augments cell death and mediates cardiac dysfunction. Similarly, following acute kidney injury, necroptosis has been shown to drive a second wave of cell death that amplifies the initial inflammation that is mediated by ferroptosis (50) .
In addition to mediating primary graft dysfunction, neutrophils have been shown to enhance alloimmune responses. To this end, it has previously been shown that neutrophilic infiltration into cardiac allografts promotes the subsequent recruitment of alloreactive T cells (51) . Notably, early graft infiltration by memory CD8 + T cells plays an important role in mediating rejection of cardiac allografts that are subjected to prolonged ischemic storage, a process that is known to be associated with enhanced neutrophilic graft infiltration (52) . Furthermore, peri-operative depletion of neutrophils or inhibition of neutrophil chemotactic pathways synergizes with co-stimulatory blockade in extending the survival of cardiac allografts (51) . Therefore, we speculate that inhibiting ferroptosis in the peri-operative period may attenuate alloimmune responses.
In conclusion, our findings provide support for the notion that ferroptotic cell death triggers initial inflammatory responses after heart transplantation. We suggest that inhibition of ferroptosis or targeting the TLR4/Trif/Type I interferon pathway may be viable clinical strategies to improve outcomes in heart transplant recipients and patients, who require reperfusion of ischemic myocardium after coronary occlusion. The recent development of platforms to perfuse and recondition organs ex vivo provides an avenue for the administration of pharmacological agents to donor grafts (53) . Our findings suggest that treating donor hearts with a ferroptosis inhibitor prior to transplantation may reduce ischemic injury. Heart transplantation. Cardiac grafts were harvested from wildtype B6 or various genedeficient donor mice and transplanted into the right neck of B6 LysM-GFP or B6 CD45.1 + hosts as previously described (9) .
Methods
Mice
Bone marrow transplantation. Bone marrow chimeras were generated as previously described (54) . Briefly, bone marrow was harvested from the femora of donor mice and T lymphocytes were depleted via negative selection with anti-CD90-labeled magnetic microbeads. Recipient mice were lethally irradiated (10 Gy) and subsequently received 1 × 10 7 T cell-depleted donor bone marrow via intravenous injection. Bone marrow chimeras were used as heart donors at least 90 days after the bone marrow transplant.
We have previously reported that this regimen results in near complete replacement of hematopoietic cells in hearts (54) .
Ischemia Reperfusion Injury.
For closed-chest IRI, two to four-month old B6 mice were anesthetized with sodium pentobarbital, intubated, and mechanically ventilated. The heart was exposed through a midline incision and an 8-0 prolene suture was placed around the proximal left coronary artery to maximize the ischemic area. The suture was then threaded through a 1 mm piece of polyethylene tubing forming a loose snare to serve as the arterial occluder. Each end of the suture was exteriorized through the thorax and stored in a subcutaneous pocket. The skin was then closed over the exteriorized suture ends with 5-0 prolene suture. Instrumented mice were allowed to recover for 2 weeks prior to induction of ischemia. Ischemia was induced after anesthetizing the animals with inhaled 1.5% isoflurane. The skin was opened over the subcutaneous pocket and the exteriorized suture exposed. The suture ends were dissected away from the subcutaneous tissue and tension was exerted until ST-segment elevation was seen on the ECG. Ischemia was confirmed by visualizing wall motion abnormalities using simultaneous echocardiography. Following 90 minutes of ischemia, tension was released and the suture ends were placed back into the subcutaneous pocket. The skin was then closed. Sham animals underwent the identical procedure with the exception that tension was not placed on the suture ends. Vehicle or Fer-1 (0.25 mg IP) was administered 24 and 2 hours before IRI. Flow cytometry. Heart tissue was prepared for flow cytometry as previously described (10) . Neutrophil chemotaxis. Neutrophils were isolated from the bone marrow of B6 mice by negative selection as previously described (10). 10 6 neutrophils, suspended in 100 μl complete RPMI medium containing 10% FBS, were placed in the upper chamber of a transwell (6.5 mm, 3-μm pore size, polycarbonate membrane, ThermoFisher Scientific).
Recombinant CXCL2 (c452-M2-010; 100 ng/ml; R&D Systems, Minneapolis, MN) and / or Fer-1 (100 µM) were added to complete RPMI medium in the lower chamber.
Neutrophil chemotaxis was assessed after a 2-hour incubation period at 37°C in 5% CO2 by counting cells using a hemocytometer in 10 μl of complete RPMI medium that were collected from the bottom chamber.
Intravital two-photon microscopy. Intravital imaging of heart grafts was performed using a custom-built 2-photon microscope running ImageWarp version 2.1 acquisition software (A&B Software, New London, CT) as previously described (9) . For time-lapse imaging of neutrophil trafficking in cardiac grafts, we averaged 15 video-rate frames (0.5 seconds per slice) during the acquisition to match the ventilator rate and minimize movement artifacts. Each plane represents an image of 220 × 240 μm in the x and y dimensions.
Twenty-one sequential planes were acquired in the z dimension (2.5 μm each) to form a Z stack. Each individual neutrophil was tracked from its first appearance in the imaging window and followed up to the time point at which it dislocated more than 20 μm from its starting position. To visualize coronary vessels and determine whether neutrophils were intravascular or extravascular we injected 50 μl of PBS containing 15 μl of 655-nm nontargeted Q-dots (ThermoFisher Scientific) intravenously immediately prior to imaging.
To determine the percentage of extravasated neutrophils, the number of extravascular neutrophils was divided by the sum of intravascular and extravascular neutrophils.
Multidimensional rendering and manual cell tracking was done with Imaris (Bitplane, Zurich, Switzerland). Data were transferred and plotted in GraphPad Prism 6.0 for creation of the graphs.
Mass spectrometric (MS) analyses of phosphatidylethanolamine and its oxidation
products. Lipids were extracted by using the Folch procedure (56) Mass spectrometric analyses of eicosanoids, docosanoids, and oxidized metabolites of linoleic acid. Mass spectrometric analyses of signaling eicosanoids, docosanoids, and oxlams were performed using a charge-switch strategy by derivatization with N-(4aminomethylphenyl) pyridinium (AMPP) and subsequent LC-MS/MS with MRM and accurate mass determination of diagnostic product ions as previously described (57) . 
IRI ex vivo (Langendorff preparations
